The biopharma world is here. Endpoints News (@endpts) is an independent news organization, reporting and analyzing the top global biotech and pharmaceutical R&D news of the day.
We produce a comprehensive daily report on biotech business deals, buyouts and corporate reorganizations to FDA actions and the latest clinical data on some of the world’s most closely watched drugs. And in this organization, the editors have complete authority to call the news as they see it.
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 15 years. Aside from his daily industry coverage for FierceBiotech, where he was named editor in 2003, leaving in 2016, Carroll has been a regular speaker at biotech events around the globe. He’s been quoted by The New York Times, The New Yorker, Financial Times, The Times of London and more. He’s also keynoted at biotech gatherings around the world and addressed student audiences at MIT and Harvard. Carroll has contributed stories from Central America and Ireland to the Dallas Morning News and Time and wrote for the Houston Press. He spent 6 years as editor and publisher of the Dallas Business Journal, was publisher of Texas Business and early in his career was part of a Pulitzer Prize-winning team of reporters and editors at the Kansas City Star & Times.
Amber Tong is an assistant editor at Endpoints, where she performs a variety of journalism tasks including copy editing, research, and writing news reports. Her beats include CRO, CMO, and drug development in China — the last of which, as a Hong Kong native, she is particularly excited about. A graduate of Rice University, she comes to Endpoints by way of Houstonia Magazine, Governing Magazine and The Chautauquan Daily. A hoarder, she is slowly building a postcard collection. Amber is based in the UK.
Shehla oversees the operations of Endpoints, with a keen eye to hitting deadlines and ensuring a consistent editorial experience across all of our news products. She contributes news items to Protocols. In her free time, you will find Shehla reading all kinds of other news besides biotech and running after her rambunctious toddler while the mild-mannered 8-year-old looks on.
Lirra Selibio handles various subscription-related inquiries and support for Endpoints News. Born in the Philippines, she enjoys the sun, the great outdoors and spending time with her pug named Lulu.
Becky has more than a decade of experience managing operations and developing efficient internal and external protocols. Her collaboration with C-suite teams from marketing, education, biotech, big data, and healthcare allows Becky to see both the big picture and the minute details. She works tirelessly in operations at Endpoints to ensure that the entire operation, from journalism to advertising buys, runs smoothly. In her personal time, Becky is just as much of a Jane-of-all-trades. She searches for WiFi reception while hiking and camping all over the US, meticulously crafts clothing and household items, researches medieval brewing and fermenting techniques, and occasionally finds the time to do writing of her own.
Igor is a web developer who leads the full stack development of all Endpoints technologies. A true citizen of the world, he’s been developing Endpoints from his travels to the Philippines, Vietnam, and Ukraine, where he is based. He passionately believes in a free and open internet and has helped translate the Declaration of Internet freedom into Ukrainian.
Dawn is a tax and financial professional with an Enrolled Agent designation under the IRS and a passion for all things involving numbers. She has an eye to improving efficiency, clarity, and accountability in all financial transactions and thrives on analysis of business practices to find ways that ensure money is being spent in a way that furthers the business. In her spare time, she is the #1 fan of her three soccer-playing boys, loves running, camping, and hiking in her local Blue Ridge Mountains, and enjoys the freedom to work remotely from anywhere she can find an internet connection.
Arsalan Arif is a journalism entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News. The former publisher of FierceMarkets’ life sciences division, he grew FierceBiotech from a small email news aggregator into a reliably profitable multimillion-dollar franchise, with a global team of editors and sales executives. Now he’s bringing some fresh ideas tempered with old-school know-how to work at Endpoints. Arsalan’s primary responsibilities at Endpoints are finance, talent recruitment, and technology development — in that order. His journalism duties include daily stewardship of the Early Edition email and covering the biopharma cybersecurity beat. The son of immigrant entrepreneurs, he received his business education by watching his parents run brick-and-mortar stores in Kansas. Arsalan was born and raised in the aviation capital of the world, Wichita, and has been a private pilot for 18 years. After spending most of his adult life in Washington, DC, he recently moved to Lawrence, Kansas, with his family. He’s on Twitter as @AKAarsalan.